Correction: DanCann Pharma A/S is reducing its debt with current lenders through a share issue by conversion of debt at market conditions
Correction of press release of 21 March 2023: In the original press release, it was stated that DanCann Pharma A/S has issued 2,031,250 shares in a directed share issue on 21 March 2023, however DanCann Pharma A/S - due to currency exchange - has issued a total of 2,130,606 shares by debt conversion which was resolved on 29 March 2023, and below is the updated press release. DanCann Pharma A/S (SS: DANCAN) (OTCQB: DCPXF) ("DanCann Pharma" or the "Company"), a Danish company powered by cannabinoids, has on 29 March 2023, based on an authorization from the general meeting, resolved to issue